Cargando…

Candida auris and endogenous panophthalmitis: clinical and histopathological features

PURPOSE: To report an unusual case of endogenous panophthalmitis involving Candida auris and describe its clinical and histopathological features. FINDINGS: A 30 year-old man with history of human immunodeficiency virus, polysubstance abuse, syphilis, and recently treated pneumonia presented with po...

Descripción completa

Detalles Bibliográficos
Autores principales: Breazzano, Mark P., Tooley, Andrea A., Godfrey, Kyle J., Iacob, Codrin E., Yannuzzi, Nicolas A., Flynn, Harry W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240712/
https://www.ncbi.nlm.nih.gov/pubmed/32462100
http://dx.doi.org/10.1016/j.ajoc.2020.100738
Descripción
Sumario:PURPOSE: To report an unusual case of endogenous panophthalmitis involving Candida auris and describe its clinical and histopathological features. FINDINGS: A 30 year-old man with history of human immunodeficiency virus, polysubstance abuse, syphilis, and recently treated pneumonia presented with polymicrobial endogenous panophthalmitis. Two separate ocular specimens confirmed simultaneous Pseudomonas aeruginosa and Candida auris involvement. Histopathological analysis demonstrated fulminant polymorphonuclear infiltration of all ocular tissue layers. Despite aggressive management including two intravitreal injections and enucleation, the patient died, ultimately after receiving care at four neighboring urban medical centers. CONCLUSIONS AND IMPORTANCE: Candida auris has been a recently and increasingly described pathogen leading to mortality in metropolitan hospitals worldwide. To the authors’ knowledge, Candida auris has not previously been reported with endophthalmitis or panophthalmitis. Future cases may be expected with the reported rise in Candida auris. A high suspicion of its contribution to panophthalmitis could be warranted early in the evaluation and management of profoundly immunocompromised patients, particularly those who have had sequential care at multiple neighboring metropolitan hospitals.